Get the Stockscreener App
5.90
1.50%
-0.09
Pre-market:
5.94
0.04
+0.68%
Septerna Inc stock is traded at $5.90, with a volume of 211.96K.
It is down -1.50% in the last 24 hours and down -6.94% over the past month.
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
See More
Previous Close:
$5.99
Open:
$5.99
24h Volume:
211.96K
Relative Volume:
0.43
Market Cap:
$269.77M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+14.34%
1M Performance:
-6.94%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$5.86
$6.21
1-Week Range:
$5.1201
$6.34
52-Week Range:
$4.17
$28.99
Septerna Inc Stock (SEPN) Company Profile
Name
Septerna Inc
Sector
Industry
Phone
650-338-3533
Address
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Compare SEPN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
5.90 | 269.77M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-19-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-19-24 | Initiated | JP Morgan | Overweight |
| Nov-19-24 | Initiated | TD Cowen | Buy |
| Nov-19-24 | Initiated | Wells Fargo | Overweight |
Septerna Inc Stock (SEPN) Latest News
Septerna Provides Corporate Overview and Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Wall Street Analysts Predict a 207.31% Upside in Septerna, Inc. (SEPN): Here's What You Should Know - NewsBreak: Local News & Alerts
Corebridge Financial Inc. Invests $212,000 in Septerna, Inc. (NASDAQ:SEPN) - Defense World
Analysts Have Conflicting Sentiments on These Technology Companies: Septerna, Inc. (SEPN) and Apple (AAPL) - The Globe and Mail
Septerna (NASDAQ:SEPN) Issues Quarterly Earnings Results - MarketBeat
Septerna (NASDAQ:SEPN) Given New $11.00 Price Target at Wells Fargo & Company - Defense World
Septerna, Inc. Reports 2024 Financial Results and Strategic Progress - TipRanks
Septerna price target lowered to $11 from $14 at Wells Fargo - TipRanks
Charles Schwab Investment Management Inc. Invests $3.20 Million in Septerna, Inc. (NASDAQ:SEPN) - Defense World
PNC Financial Services Group Inc. Purchases New Position in Septerna, Inc. (NASDAQ:SEPN) - Defense World
Septerna reports Q4 EPS (64c), consensus (69c) - TipRanks
Septerna Provides Corporate Overview And Reports Fourth Quarter And Full Year 2024 Financial Results - Marketscreener.com
Form 10-K Septerna, Inc. For: Dec 31 - StreetInsider.com
Septerna Discontinues Key Drug Trial: What's Next for $420M Biotech Pipeline? - Stock Titan
Bank of New York Mellon Corp Buys Shares of 38,093 Septerna, Inc. (NASDAQ:SEPN) - Defense World
SEPN Investors Have Opportunity to Join Septerna, Inc. Fraud Investigation with the Schall Law Firm - The Malaysian Reserve
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Septerna, Inc.SEPN - PR Newswire
Septerna, Inc. (SEPN): Among Top Insider Purchases Last Month - MSN
Top 10 Insider Purchases Last Month - Insider Monkey
Director Makes Bold Move with Major Stock Purchase in Septerna, Inc. - TipRanks
Rhumbline Advisers Invests $458,000 in Septerna, Inc. (NASDAQ:SEPN) - Defense World
Septerna director Alan Ezekowitz buys $515,934 in common stock By Investing.com - Investing.com Canada
Septerna director Alan Ezekowitz buys $515,934 in common stock - Investing.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Septerna, Inc. (SEPN) And Encourages Shareholders to Reach Out - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Septerna, Inc. (SEPN) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Septerna, Inc. (SEPN): Among The Stocks With At Least $30 Million In Insider Spending Recently - Insider Monkey
10 Stocks With At Least $30 Million In Insider Spending Recently - Insider Monkey
Insiders Are Loading Up on These 6 Stocks Now - 24/7 Wall St.
Septerna, Inc. (SEPN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
Septerna, Inc. Shifts Focus to Next-Gen PTH1R Agonist - TipRanks
Bronstein, Gewirtz & Grossman, LLC Encourages Septerna, Inc. (SEPN) Shareholders to Inquire about Securities Investigation - Markets Insider
Septerna, Inc. (SEPN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Is Investigating Septerna, Inc. (SEPN) And Encourages Investors to Connect - Markets Insider
Septerna CEO Jeffrey Finer acquires $96,960 in stock By Investing.com - Investing.com India
Top Executives at Septerna, Inc. Make Bold Stock Purchases! - TipRanks
Septerna CFO Labrucherie buys $56,866 in common stock By Investing.com - Investing.com South Africa
Septerna CFO Labrucherie buys $56,866 in common stock - Investing.com India
Septerna CEO Jeffrey Finer acquires $96,960 in stock - Investing.com
Bronstein, Gewirtz & Grossman, LLC Encourages Septerna, Inc. (SEPN) Stockholders to Inquire about Securities Investigation - Markets Insider
Major Investment Alert: Third Rock Ventures Boosts Stake in Septerna, Inc. - TipRanks
Third Rock Ventures purchases $113,147 in Septerna stock - Investing.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Septerna, Inc. (SEPN) and Encourages Investors to Learn More About the Investigation - Markets Insider
Septerna to Present at TD Cowen 45th Annual Health Care Conference - The Manila Times
Septerna Inc Stock (SEPN) Financials Data
There is no financial data for Septerna Inc (SEPN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):